Your binder contains too many pages, the maximum is 40.
We are unable to add this page to your binder, please try again later.
This page has been added to your binder.
January 15, 2015
LONDON, January 15, 2015 — Covington & Burling advised Laboratorios Esteve, S.A. (Esteve) in a global multi-programme discovery and development collaboration with Mundipharma Laboratories GmbH and its independent associated company, Purdue Pharmaceuticals LP, to bring to market important next generation products for the management of pain. Under the agreements, Mundipharma and Purdue could potentially make payments to Esteve exceeding $1 billion if all development, regulatory and sales milestones are met across the different programmes.The London-based Covington team comprised of partner James Halstead and of counsel Morag Peberdy.